Skip to content
Tech News
← Back to articles

White House withdraws FDA nominee Overton; Senate HELP Committee drops NSF pick vote

read original more articles
GoKawiil Brief

The White House withdrew its nomination of Heidi Overton to lead the FDA late Tuesday, according to Axios, after she faced bipartisan criticism over her stances on vaccines, abortion, vapes and birth control and repeatedly declined to answer senators' questions during her September confirmation hearing. Separately, the Senate's HELP Committee canceled its scheduled Wednesday vote on Overton's nomination, and a Trump administration official said she lacked sufficient Senate support to be confirmed. Committee chair Bill Cassidy said he believed Overton had a viable path to confirmation but that it was abandoned after some anti-abortion senators sought commitments from her.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

The withdrawal suggests the administration judged that Overton's evasive answers on vaccine safety and abortion pill policy had cost her support even among sympathetic Republicans, not just Democrats. It leaves the FDA without a confirmed leader at a moment when the agency faces reviews of mifepristone safety and ongoing vaccine policy disputes shaped by Kennedy-aligned views. The near-simultaneous stumble of Trump's NSF pick points to broader friction between the administration's nominees and a Senate wary of candidates seen as unwilling to commit to independent, science-based positions.

Key Takeaways

Source: arstechnica.com, 2026-11-18

Published there as: “Trump abandons his FDA nominee, and Senate scraps vote on his NSF pick”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.
Keep reading
national science foundation 6 briefs →